VMI

VHCP Management II Portfolio holdings

AUM $379M
1-Year Est. Return 424.39%
This Quarter Est. Return
1 Year Est. Return
+424.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$379M
AUM Growth
+$117M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
29
New
Increased
Reduced
Closed

Top Buys

1
+$36.5M
2
+$8.62M
3
+$5.29M
4
RLMD icon
Relmada Therapeutics
RLMD
+$4.48M
5
ADVM
Adverum Biotechnologies
ADVM
+$4.42M

Top Sells

1
+$22.6M
2
+$16M
3
+$15.7M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$13.6M
5
AXSM icon
Axsome Therapeutics
AXSM
+$11.1M

Sector Composition

1 Healthcare 99.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNSA icon
26
Kiniksa Pharmaceuticals
KNSA
$2.99B
– –
-540,461
KA
27
DELISTED
Kineta, Inc. Common Stock
KA
– –
-934
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
– –
-13,667
RARX
29
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-677,164
1
2